Navigation Links
New hope for stem cells, regenerative medicine emerges from the lab
Date:12/17/2013

Today, December 17, JoVE, the Journal of Visualized Experiments, has published a novel technique that could resolve a snag in stem cell research for application in regenerative medicinea strategy for reprograming cells in vivo to act like stem cells that forgoes the risk of causing tumors.

Dr. Kostas Kostarelos, principal investigator of the Nanomedicine Lab at the University of Manchester, said that he and his colleagues have discovered a safe approach to reprogramming somatic cells (which constitute most of the cells in the body) into induced pluripotent stem (iPS) cells. Research in this field has been embraced as an alternative to the controversial use of embryonic stem cells.

"We have induced somatic cells within the liver of adult mice to transiently behave as pluripotent stem cells," said Dr. Kostas Kostarelos, the lab's principal investigator, "This was done by transfer of four specific genes, previously described by the Nobel-prize winning Shinya Yamanaka, without the use of viruses but simply plasmid DNA [a small circular, double-stranded piece of DNA used for manipulating gene expression in a cell]."

The technique comes as an alternative to Dr. Shinya Yamanaka's reprograming methods, which won him the Nobel prize in 2012. Dr. Yamanaka's approach involved reprogramming somatic cells in vitro by introducing four genes through the use of a virus. While promising, the use of this method has been limited. As Dr. Kostarelos's article states, "One of the central dogmas of this emerging field is that in vivo implantation of [these stem] cells will lead to their uncontrolled differentiation and the formation of a tumor-like mass."

Dr. Kostarelos and his team have determined that their technique does not share the risk of uncontrolled stem cell growth into tumors as seen in in vitro, viral-based methods. "[This is the] only experimental technique to report the in vivo reprogramming of adult somatic cells to pluripotency using non-viral, transient, rapid and safe methods," Kostarelos said.

The Nanomedicine Lab's approach involves injecting large volumes of plasmid DNA to reprogram cells. However, because plasmid DNA is short-lived in this scenario, the risk of uncontrolled growth is reduced.

The research group chose to publish their technique with JoVE as a means to emphasize the novelty, uniqueness and simplicity of their procedure. Along with their article, a demonstration of their technique has been published as a peer-reviewed video to ensure the proper replication of this technique by other researchers in the field.


'/>"/>

Contact: Rachel Greene
rachel.greene@jove.com
617-250-8451
The Journal of Visualized Experiments
Source:Eurekalert  

Related biology news :

1. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
2. Cell receptor has proclivity for T helper 9 cells, airway inflammation
3. First dual-action compound kills cancer cells, stops them from spreading
4. Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors
5. Colon cancer researchers target stem cells, discover viable new therapeutic path
6. Genetic research develops tools for studying diseases, improving regenerative treatment
7. Gallbladder shown as potential stem cell source for regenerative liver and metabolic disease
8. Discovery of reprogramming signature may help further stem cell-based regenerative medicine research
9. SDSU opens new regenerative research institute
10. IUPUI stem cell research could expand clinical use of regenerative human cells
11. Advance in regenerative medicine could make reprogrammed cells safer while improving their function
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New hope for stem cells, regenerative medicine emerges from the lab
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... fastest growing genetic information companies, today announced that it ... results and provide 2017 guidance on Monday, February 13, ... call that day at 4:45 p.m. Eastern / 1:45 ... management team will briefly review financial results, guidance, and ...
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... 2017 , ... LabRoots , the leading provider of educational and interactive ... to announce the launch of a new scholarship for young scientists seeking a degree ... scholarship is open to all high school seniors, 17 years or older; as well ...
(Date:2/22/2017)... Zurich, Switzerland (PRWEB) , ... February 22, 2017 ... ... Ltd ., announced the addition of Tom Perkins as European director. Operating from ... consulting experience to Pennside. , Perkins joins Pennside after more than a ...
(Date:2/21/2017)... ... February 21, 2017 , ... During HIMSS 2017, CloudMine, a ... announced a partnership with Redox, a leader in cloud-based healthcare integration and API ... while keeping data secure in the cloud. , The digital health developers, and ...
(Date:2/21/2017)... (PRWEB) , ... February 21, ... ... the Life -Sciences division, Treximo will pair its $200M operational capacity with ... consulting and project management in areas affecting quality and operational management. ...
Breaking Biology Technology: